PTGS2 and lung cancer: Consistent with previous reports showing that COX2 expression is associated with lung cancer progression [36, 37], we observed a dramatic increase in COX2 expression in HBECs modified to contain oncogenic K-rasV12 (Fig 3A and 3B).